Zhu Ping, Zhang Yongyan, Xu Hua, Ren Yu
Department of Anesthesiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai, China.
Front Behav Neurosci. 2025 Jun 2;19:1607421. doi: 10.3389/fnbeh.2025.1607421. eCollection 2025.
Parkinson's disease (PD) is associated with higher risk of cognitive impairment. Until now, little is known about the effect of anesthetics on cognitive function in PD patients. The imbalance of hippocampal N-methyl-D-aspartate (NMDA) receptors NR2A/NR2B subunit ratio is reported to be associated with memory dysfunction in PD rats. The current study investigated the effects of propofol on the cognitive function and hippocampal NR2A/NR2B ratio in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD rat model.
MPTP was stereotaxically injected into the substantia nigra pars compacta of male Wistar rats. Next day (day 2), the rats in the chronic intervention groups were injected daily with either propofol (80 mg/kg/day, i.p.) or fat emulsion for 7 days (day 2-8). The rats in the acute intervention groups received propofol or fat emulsion only on day 8. Then, all the rats underwent an open field test and an inhibitory avoidance (IA) test. At last, the rats were killed for histological analysis and hippocampal NR2A and NR2B proteins and mRNA level quantification.
Neither acute nor chronic treatment with propofol can significantly change the impairment of locomotor activity and dopaminergic denervation of the striatum in MPTP-lesioned rats. MPTP lesioning caused IA memory impairment, which was aggravated by chronic treatment with propofol. Furthermore, chronic treatment with propofol also aggravated the imbalance of hippocampal NR2A/NR2B ratio in MPTP-lesioned rats.
The current findings indicate that chronic propofol treatment exacerbated MPTP-induced inhibitory avoidance (IA) memory impairment and aggravated the imbalance of hippocampal NR2A/NR2B ratio in MPTP-lesioned rats. Our current data demonstrate a correlation, not direct causation, between NR2A/NR2B dysregulation and cognitive impairment. Future studies should probe whether this imbalance is a driver or consequence of synaptic dysfunction.
帕金森病(PD)与认知障碍风险较高相关。迄今为止,关于麻醉药对PD患者认知功能的影响知之甚少。据报道,海马N-甲基-D-天冬氨酸(NMDA)受体NR2A/NR2B亚基比例失衡与PD大鼠的记忆功能障碍有关。本研究在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的PD大鼠模型中,研究了丙泊酚对认知功能和海马NR2A/NR2B比例的影响。
将MPTP立体定向注射到雄性Wistar大鼠的黑质致密部。第二天(第2天),慢性干预组的大鼠每天腹腔注射丙泊酚(80mg/kg/天)或脂肪乳剂,持续7天(第2 - 8天)。急性干预组的大鼠仅在第8天接受丙泊酚或脂肪乳剂。然后,所有大鼠接受旷场试验和抑制性回避(IA)试验。最后,处死大鼠进行组织学分析以及海马NR2A和NR2B蛋白及mRNA水平定量。
丙泊酚急性或慢性治疗均不能显著改变MPTP损伤大鼠的运动活动损害和纹状体多巴胺能去神经支配。MPTP损伤导致IA记忆障碍,丙泊酚慢性治疗会使其加重。此外,丙泊酚慢性治疗还加剧了MPTP损伤大鼠海马NR2A/NR2B比例的失衡。
目前的研究结果表明,丙泊酚慢性治疗加剧了MPTP诱导的抑制性回避(IA)记忆障碍,并加重了MPTP损伤大鼠海马NR2A/NR2B比例的失衡。我们目前的数据表明NR2A/NR2B失调与认知障碍之间存在相关性,而非直接因果关系。未来的研究应探究这种失衡是突触功能障碍的驱动因素还是结果。